Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLERO-3: Everolimus with Trastuzumab and Vinorelbine in HER2+ Breast Cancer
NCT01007942Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2009
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by Novartis. Started Oct 2009; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01007942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007942.